Home » Latest Research Trends » Latest Research Trends (17 Jan 2025)

Latest Research Trends (17 Jan 2025)

Delivery of Prime editing in human stem cells

Journal: Nature Communications

Author: Thibaut Halegua et al., France

Novel NanoScribes particle system enables efficient prime editing in human stem cells.

Development of virus-like particles for delivering prime editing components achieves up to 68% editing efficiency in HEK293T cells and 25% in stem cells.

Comprehensive genomic characterization of early-stage bladder cancer

Journal: Nature Genetics

Author: Frederik Prip et. al, Denmark

Multi-omics analysis reveals genomic instability patterns in non-muscle invasive bladder cancer.

The study analyzed 438 NMIBC cases using multi-omics approach, identifying WGD in 15% of tumors linked to poor outcomes and revealing key roles of genomic instability in disease progression.

ABCF1-K430-Lactylation in HCC”

Journal: Cell Death & Differentiation

Author: Han Hong et. al, China

Novel lactylation mechanism of ABCF1 promotes liver cancer progression through HIF1 pathway

Study identifies ABCF1-K430la as prognostic marker in HCC, revealing its role in cancer progression through KDM3A-H3K9me2-HIF1A axis activation and identifying tubuloside A as potential therapeutic.

Intratumoral mRNA vaccine administration

Journal: Cell Discovery

Author: Renhao Li et. al, China

Novel cancer immunotherapy strategy using intratumoral mRNA vaccines leverages existing pathogen immunity.

This researchs uses the innovative approach of the COVID-19 vaccine technology for cancer treatment, showing promising results in solid tumors, particularly effective when combined with anti-PD-L1 therapy.

Subscribe
to the latest updates in the newsletter

Related Solutions

  • Disease Modeling
  • Oncology
  • Organoid
  • Cosmetics
  • OECD TG
  • Zebrafish
  • Bioinfomatics
  • Live&3D Imaging
  • Molecular biology
  • Spatial Biology
Technical Service

Next Articles

Thank you for your submission.

Our team has received your request and will get back to you shortly with tailored workflows and relevant case studies for your ADC efficacy and toxicity evaluation needs.
If you do not receive our confirmation email, kindly check your spam or junk folder.

Thank you for your insterest

You can now download the file.

Connect with Us